These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29113303)

  • 1. Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation.
    Jiang MY; Han ZD; Li W; Yue F; Ye J; Li B; Cai Z; Lu JM; Dong W; Jiang X; Zhong W; He H; Liu L
    Oncotarget; 2017 Oct; 8(46):80295-80302. PubMed ID: 29113303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of autophagy flux in benign prostatic hyperplasia in vitro.
    Oh SH; Lee DW; Choi YB; Lee YH; Ju JS
    Prostate Int; 2020 Jun; 8(2):70-77. PubMed ID: 32647643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia.
    Jin S; Liu Z; Xiang P; Fu M; Zhang G; Li J; Niu Y
    World J Urol; 2024 May; 42(1):333. PubMed ID: 38761255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia.
    Castro P; Xia C; Gomez L; Lamb DJ; Ittmann M
    Prostate; 2004 Jul; 60(2):153-9. PubMed ID: 15162381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of androgen induces autophagy in benign prostate epithelial cells.
    Li M; Yang X; Wang H; Xu E; Xi Z
    Int J Urol; 2014 Feb; 21(2):195-9. PubMed ID: 23819759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-383 promotes reactive oxygen species-induced autophagy via downregulating peroxiredoxin 3 in human glioma U87 cells.
    Xu Z; Zeng X; Li M; Liao J; Chen Q
    Exp Ther Med; 2021 May; 21(5):439. PubMed ID: 33747176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy in benign prostatic hyperplasia: insights and therapeutic potential.
    Zhou XZ; Huang P; Wu YK; Yu JB; Sun J
    BMC Urol; 2024 Sep; 24(1):198. PubMed ID: 39261818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.
    Barclay WW; Woodruff RD; Hall MC; Cramer SD
    Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress promotes benign prostatic hyperplasia.
    Vital P; Castro P; Ittmann M
    Prostate; 2016 Jan; 76(1):58-67. PubMed ID: 26417670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.
    Wu Q; Zhou Y; Chen L; Shi J; Wang CY; Miao L; Klocker H; Park I; Lee C; Zhang J
    J Endocrinol; 2007 Oct; 195(1):89-94. PubMed ID: 17911400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
    Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
    BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis.
    Xu G; Yue F; Huang H; He Y; Li X; Zhao H; Su Z; Jiang X; Li W; Zou J; Chen Q; Liu L
    Aging (Albany NY); 2016 May; 8(5):977-85. PubMed ID: 27236336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6/STAT3/Cyclin D1 signals.
    Ou Z; He Y; Qi L; Zu X; Wu L; Cao Z; Li Y; Liu L; Dube DA; Wang Z; Wang L
    Oncotarget; 2017 Aug; 8(35):59156-59164. PubMed ID: 28938626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS; Walsh PC
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.